RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+9.66%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$2.04B
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,493
Increased
1,679
Reduced
1,236
Closed
38
Top Buys
| 1 |
Tesla
TSLA
|
+$73.3M |
| 2 |
Microsoft
MSFT
|
+$65.3M |
| 3 |
TSMC
TSM
|
+$64.1M |
| 4 |
Apple
AAPL
|
+$61.4M |
| 5 |
Palo Alto Networks
PANW
|
+$58.3M |
Top Sells
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Wells Fargo
WFC
|
+$26.4M |
| 4 |
Chevron
CVX
|
+$24.6M |
| 5 |
Crane NXT
CXT
|
+$15M |
Sector Composition
| 1 | Technology | 27.29% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Northrim BanCorp
NRIM
$508M
| $226K | ﹤0.01% |
+5,754
| New | +$226K |
|
3027
Traeger
COOK
$178M
| $226K | ﹤0.01% |
53,221
+1,079
| +2% | +$4.59K |
|
|
EDR
3028
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $225K | ﹤0.01% |
+9,421
| New | +$225K |
|
|
NOAH
3029
Noah Holdings
NOAH
$787M
| $225K | ﹤0.01% |
+15,976
| New | +$225K |
|
3030
Biglari Holdings Class B
BH
$951M
| $225K | ﹤0.01% |
1,141
-66
| -5% | -$13K |
|
3031
FiscalNote
NOTE
$73M
| $224K | ﹤0.01% |
+5,128
| New | +$224K |
|
3032
Fidelity D&D Bancorp
FDBC
$260M
| $223K | ﹤0.01% |
+4,594
| New | +$223K |
|
3033
First Western Financial
MYFW
$226M
| $223K | ﹤0.01% |
11,994
-374
| -3% | -$6.96K |
|
|
JBIO
3034
Jade Biosciences, Inc. Common Stock
JBIO
$247M
| $223K | ﹤0.01% |
371
-52
| -12% | -$31.2K |
|
3035
Enel Chile
ENIC
$5.02B
| $222K | ﹤0.01% |
+66,655
| New | +$222K |
|
3036
Rocky Brands
RCKY
$216M
| $222K | ﹤0.01% |
10,564
-43
| -0.4% | -$903 |
|
|
LOGC
3037
DELISTED
ContextLogic
LOGC
| $222K | ﹤0.01% |
33,667
+3,869
| +13% | +$25.5K |
|
3038
SkyWater Technology
SKYT
$474M
| $221K | ﹤0.01% |
23,512
+5,576
| +31% | +$52.5K |
|
3039
Zevra Therapeutics
ZVRA
$448M
| $220K | ﹤0.01% |
+43,163
| New | +$220K |
|
3040
Actinium Pharmaceuticals
ATNM
$50.2M
| $220K | ﹤0.01% |
+29,650
| New | +$220K |
|
|
BNL
3041
DELISTED
BUNZL PLC ADS (RP 5 ORD SHS)
BNL
| $220K | ﹤0.01% |
+5,760
| New | +$220K |
|
3042
Stratus Properties
STRS
$154M
| $220K | ﹤0.01% |
+8,373
| New | +$220K |
|
|
NHY
3043
DELISTED
NORSK HYDRO A. S. ADR
NHY
| $218K | ﹤0.01% |
+36,680
| New | +$218K |
|
3044
James Hardie Industries plc
JHX
$11.5B
| $218K | ﹤0.01% |
+8,116
| New | +$218K |
|
|
KLRS
3045
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.1M
| $217K | ﹤0.01% |
2,777
+673
| +32% | +$52.6K |
|
3046
Bankwell Financial Group
BWFG
$350M
| $217K | ﹤0.01% |
8,907
-82
| -0.9% | -$2K |
|
3047
Baytex Energy
BTE
$1.83B
| $217K | ﹤0.01% |
+66,590
| New | +$217K |
|
3048
Celcuity
CELC
$2.37B
| $217K | ﹤0.01% |
+19,759
| New | +$217K |
|
|
TVRD
3049
Tvardi Therapeutics, Inc. Common Stock
TVRD
$308M
| $217K | ﹤0.01% |
2,129
-2,171
| -50% | -$221K |
|
3050
Rallybio
RLYB
$25.1M
| $216K | ﹤0.01% |
38,186
+15,080
| +65% | +$85.4K |
|